دورية أكاديمية
أعرض في EDS

Drug utilization in the Maastricht Study: A comparison with nationwide data.

التفاصيل البيبلوغرافية
العنوان: Drug utilization in the Maastricht Study: A comparison with nationwide data.
المؤلفون: Nielen JTH; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht., Driessen JHM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht.; School for nutrition, and translational research in metabolism (NUTRIM), Maastricht University., Dagnelie PC; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Epidemiology, Maastricht University.; School for Public Health and Primary Care (CAPHRI), Maastricht University., Boonen A; School for Public Health and Primary Care (CAPHRI), Maastricht University.; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center +, Maastricht., van den Bemt B; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; Department of Pharmacy, Sint Maartenskliniek.; Department of Pharmacy, Radboud University Medical Center, Nijmegen., van Onzenoort HAW; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; Department of Clinical Pharmacy, Amphia Hospital, Breda., Neef C; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center., Henry RMA; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Burden AM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, Eidgenossische Technische Hochschule Zurich, Zurich, Switzerland., Sep SJS; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., van der Kallen CJ; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Schram MT; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Schaper N; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Epidemiology, Maastricht University.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Stehouwer CDA; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Department of Epidemiology, Maastricht University.; Department of Internal Medicine, Maastricht University Medical Center +, Maastricht, The Netherlands., Smits L; Department of Epidemiology, Maastricht University., de Vries F; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center.; School for Cardiovascular Diseases (CARIM), Maastricht University, Maastricht.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht.
المصدر: Medicine [Medicine (Baltimore)] 2020 Jan; Vol. 99 (1), pp. e18524.
نوع المنشور: Comparative Study; Journal Article; Observational Study
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*drug therapy , Drug Utilization/*statistics & numerical data , Population Health/*statistics & numerical data, Aged ; Anti-Anxiety Agents/therapeutic use ; Female ; Humans ; Hypnotics and Sedatives/therapeutic use ; Male ; Middle Aged ; Netherlands/epidemiology ; Prospective Studies ; Respiratory System Agents/therapeutic use
مستخلص: Within the southern region of the Netherlands, the Maastricht Study is an on-going observational prospective population-based cohort study that focuses on the etiology of Type 2 diabetes mellitus (T2DM). Representativeness of the participating population is a crucial but often an unknown factor in population-based cohort studies such as the Maastricht Study. We therefore aimed to assess the representativeness of the study population by comparing drug utilization of the participants of the Maastricht Study with the general population of the Netherlands.Since T2DM patients were oversampled in this study, a sampling method was applied in order to ensure a similar distribution of T2DM over the study population. Drug use in the study population was compared with drug use in the population of the Netherlands, using a Z-test to compare 2 independent proportions.In general, drug use in the study was similar compared with national data. However, in the age group 65 to 74 years total drug use was lower in the study population (833/1000 persons) versus nationwide data (882/1000 persons). The use of pulmonary medications was lower (104/1000 persons vs 141/1000 persons) and the use of hypnotics/anxiolytics was higher (90/1000 persons vs 36/1000 persons) in the Maastricht Study as compared with national data.Drug use in the Maastricht Study population is largely comparable to that in the total Dutch population aged 45 to 74. Therefore, data on drug use by participants in the Maastricht Study can be used to perform studies assessing outcomes associated with drug use.
References: J Public Health (Oxf). 2006 Sep;28(3):278-82. (PMID: 16905714)
Ann Epidemiol. 1995 May;5(3):245-9. (PMID: 7606315)
Diabetes Obes Metab. 2016 Mar;18(3):258-65. (PMID: 26537555)
Eur J Epidemiol. 2014 Jun;29(6):439-51. (PMID: 24756374)
Ann Epidemiol. 1999 Apr;9(3):188-95. (PMID: 10192651)
J Clin Epidemiol. 1996 Dec;49(12):1441-46. (PMID: 8970495)
Br J Surg. 2014 Apr;101(5):481-7. (PMID: 24615380)
Am J Epidemiol. 2001 Sep 15;154(6):574-81. (PMID: 11549563)
Ann Epidemiol. 2004 Sep;14(8):579-84. (PMID: 15350958)
Neth J Med. 2017 Sep;75(7):281-297. (PMID: 28956787)
Medicine (Baltimore). 2015 Aug;94(32):e1358. (PMID: 26266391)
Int J Epidemiol. 2007 Dec;36(6):1292-9. (PMID: 17898025)
المشرفين على المادة: 0 (Anti-Anxiety Agents)
0 (Hypnotics and Sedatives)
0 (Respiratory System Agents)
تواريخ الأحداث: Date Created: 20200103 Date Completed: 20200114 Latest Revision: 20221005
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC6946313
DOI: 10.1097/MD.0000000000018524
PMID: 31895787
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-5964
DOI:10.1097/MD.0000000000018524